21 Recruiting Studies at University Of Arizona Cancer Center
Active clinical trials at this research center, sourced directly from the NIH registry.
π Tucson, Arizona
All research centersRecruiting Studies at University Of Arizona Cancer Center
π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
Breast Cancer
View Study & Checklist β π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma
View Study & Checklist β π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
Hepatocellular Carcinoma
View Study & Checklist β π΅ Active, Not Recruiting Observational / Diagnostic π§ Behavioral & Psychological Program
Hispanic Adapted and Culturally Relevant Exercising Together
Neoplasms
View Study & Checklist β π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer
Pancreatic Cancer
View Study & Checklist β π΅ Active, Not Recruiting Phase1 / Phase2 π Investigational Drug / Biologic
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
Unresectable or Metastatic Melanoma or Advanced Solid Tumors
View Study & Checklist β π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
Intravesical Gem/Doce in Patients With NMIBC
Urinary Bladder Cancer
View Study & Checklist β π‘ Not Yet Recruiting Early Phase1 π Investigational Drug / Biologic
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
Pancreatic Cancer
View Study & Checklist β π’ Recruiting Phase1 / Phase2 π Investigational Drug / Biologic
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Advanced Solid Tumor
View Study & Checklist β π’ Recruiting Phase1 π Investigational Drug / Biologic
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
Advanced Solid Tumor
View Study & Checklist β π’ Recruiting Phase1 π Investigational Drug / Biologic
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Advanced Solid Tumors
View Study & Checklist β π’ Recruiting Phase1 / Phase2 π Investigational Drug / Biologic
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Breast Cancer
View Study & Checklist β π’ Recruiting Observational / Diagnostic π§ Behavioral & Psychological Program
A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
Cancer
View Study & Checklist β π’ Recruiting Observational / Diagnostic π§ Behavioral & Psychological Program
Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers
Cancer Metastatic
View Study & Checklist β π’ Recruiting Phase1 π Investigational Drug / Biologic
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Colorectal Neoplasms
View Study & Checklist β π’ Recruiting Phase3 π Investigational Drug / Biologic
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Follicular Lymphoma (FL)
View Study & Checklist β π’ Recruiting Phase2 π Investigational Drug / Biologic
A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma
HER2/Neu+ Uterine Serous Carcinoma
View Study & Checklist β π’ Recruiting Observational / Diagnostic π§ Behavioral & Psychological Program
The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer
Lung Cancer - Non Small Cell
View Study & Checklist β π’ Recruiting Observational / Diagnostic π Clinical Research Protocol
SUV PDL1/PD1 in Sun Damaged & Sun Protected Human Skin of Participants
Other Skin Changes Due to Chronic Exposure to Nonionizing Radiation
View Study & Checklist β π’ Recruiting Phase1 π Investigational Drug / Biologic
A Study of HC-7366 in Combination With Belzutifan (WELIREGβ’) in Patients With Renal Cell Carcinoma
Renal Cell Carcinoma
View Study & Checklist β π’ Recruiting Phase1 / Phase2 π Investigational Drug / Biologic
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
Solid Tumor Malignancies
View Study & Checklist β